TRICIDA INC's ticker is TCDA and the CUSIP is 89610F101. A total of 104 filers reported holding TRICIDA INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,868 | -100.0% | 25,300 | -96.6% | 0.00% | -100.0% |
| Q3 2022 | $7,898,000 | +684.3% | 753,600 | +624.6% | 0.20% | +629.6% |
| Q2 2022 | $1,007,000 | +225.9% | 104,000 | +56.3% | 0.03% | +200.0% |
| Q3 2021 | $309,000 | -19.7% | 66,550 | -25.2% | 0.01% | -25.0% |
| Q2 2021 | $385,000 | -10.0% | 89,023 | +9.9% | 0.01% | -25.0% |
| Q1 2021 | $428,000 | -32.4% | 80,993 | -9.7% | 0.02% | -33.3% |
| Q4 2020 | $633,000 | +75.8% | 89,727 | +584.1% | 0.02% | -4.0% |
| Q2 2020 | $360,000 | +20.4% | 13,116 | -3.4% | 0.02% | 0.0% |
| Q1 2020 | $299,000 | -32.2% | 13,572 | -5.0% | 0.02% | -37.5% |
| Q3 2019 | $441,000 | -11.8% | 14,283 | +12.8% | 0.04% | -11.1% |
| Q2 2019 | $500,000 | -37.7% | 12,661 | -39.1% | 0.04% | -42.3% |
| Q1 2019 | $803,000 | – | 20,791 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 7,132,079 | $69,039,000 | 13.60% |
| STONEHILL CAPITAL MANAGEMENT LLC | 1,436,736 | $13,908,000 | 9.25% |
| COMMODORE CAPITAL LP | 2,028,453 | $19,635,000 | 4.15% |
| Tri Locum Partners LP | 731,142 | $7,077,000 | 2.90% |
| GREAT POINT PARTNERS LLC | 1,164,763 | $11,275,000 | 2.70% |
| Frazier Life Sciences Management, L.P. | 2,082,093 | $20,155,000 | 1.90% |
| Orbimed Advisors | 10,280,947 | $99,520,000 | 1.80% |
| Deep Track Capital, LP | 2,732,117 | $26,447,000 | 1.74% |
| Lion Point Capital, LP | 1,826,729 | $12,034,000 | 1.37% |
| Bleichroeder LP | 450,000 | $4,356,000 | 0.90% |